Type II diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention: injection of Vitamin D 400000 IU first and one month after the start of the study each time 200,000 IU
Duration of study 2 months.
The control group does not receive anything..
Treatment - Drugs
Intervention: injection of Vitamin D 400000 IU first and one month after the start of the study each time 200,000 IU
Duration of study 2 months.
The control group does not receive anything.
Sponsors
Shahid Sadoughi University of Medical Sciences Yazd
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: inclusion: Diabetes mellitus patients and HbA1c hemoglobin less than 9 percent 2-25 levels of hydroxyvitamin D (25 OHD) less than 20 ng / ml 3- Age range 30-60 years and Exclusion criteria:1 - Lack of interest in participating in the study-2-Use of vitamin D supplementation over the past 3 months-3-Kidney,liver disease,Malabsorption syndrome,Severe infection-4-Use of immunosuppressive drugs-5- Pregnancy and lactation- 6- Use of insulin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| E-Selectin of serum. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: ELISA method.;High-sensitivity C-reactive protein (hs-CRP) of serum. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: ELISA method.;Serum fasting blood sugar(FBS). Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Vitamin D of serum. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: ELISA method.;Serum total cholesterol. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Serum triglyceride level (TG). Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Serum high density lipoprotein cholesterol (HDL-C). Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Serum low Density Lipoprotein cholesterol (LDL-C). Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Serum Calcium. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method.;Serum Phosphorus. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Enzymatic method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: by body Calibrated scale.;Body mass index. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: by body Calibrated scale.;Body fat percent. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: by body Calibrated scale.;Muscle mass percent. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: by body Calibrated scale.;Visceral fat percent. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: by body Calibrated scale.;Evalution of patients diet. Timepoint: Before the intervention and two months after the start of the study. Method of measurement: Three-day food record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFARHANG MIRZAVANDI
Shahid Sadoughi University of Medical Sciences and Health Services Yazd
Outcome results
None listed